Author details

Full Name

Agnes Viale

Affiliation

Memorial Sloan Kettering Cancer Center

ORCID

Career Start Year

1996

Papers

170

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36862133	Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.	Clin Cancer Res	2023
34847567	An autoimmune stem-like CD8 T cell population drives type 1 diabetes.	Nature	2022
35585047	Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.	Nat Commun	2022
35626002	Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer.	Cancers (Basel)	2022
36517593	Ovarian cancer mutational processes drive site-specific immune evasion.	Nature	2022
36564410	Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.	Nat Commun	2022
36002234	A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes.	J Immunol	2022
36323682	FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.	Nat Commun	2022
33217552	Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Real-Time RT-PCR Tests on Oral Rinses and Saliva Samples.	J Mol Diagn	2021
33877327	Measuring nonhomologous end-joining, homologous recombinationÂ and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell.	Nucleic Acids Res	2021
33564192	Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.	Nat Med	2021
33562682	NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy.	Cancers (Basel)	2021
33632898	Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.	Cancer Res	2021
34059130	Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.	Genome Med	2021
32641410	Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.	Cancer Res	2020
33163850	Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs.	JCO Precis Oncol	2020
32747829	Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.	Nat Med	2020
32633890	Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.	Cancer Med	2020
32603443	Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood.	J Appl Lab Med	2020
30567753	Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.	Blood	2019
30185420	Lobular Carcinomas <i>In Situ</i> Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.	Clin Cancer Res	2019
31237614	Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.	J Clin Endocrinol Metab	2019
31485558	Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.	JCO Precis Oncol	2019
31398338	The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.	Cell	2019
30842593	Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.	Nat Cell Biol	2019
30706231	Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.	Ann Surg Oncol	2019
31142587	c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma.	J Exp Med	2019
30675060	Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.	Nature	2019
29316426	Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.	Cancer Cell	2018
30205045	The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.	Cancer Cell	2018
30355724	Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.	Cancer Discov	2018
29559475	Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple Myeloma.	Cancer Res	2018
29180607	Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.	Clin Cancer Res	2018
27751729	Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.	Eur Urol	2017
28351929	Genetic Heterogeneity in Therapy-NaÃ¯ve Synchronous Primary Breast Cancers and Their Metastases.	Clin Cancer Res	2017
29629425	Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomas.	JCO Precis Oncol	2017
29285228	Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.	Oncotarget	2017
28514453	Chromatin states define tumour-specific T cell dysfunction and reprogramming.	Nature	2017
28619981	Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.	Cancer Discov	2017
27836862	Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.	Clin Cancer Res	2017
26837003	Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.	Nat Commun	2016
27863426	Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.	Oncotarget	2016
27447490	KRAS AND THE REALITY OF PERSONALIZED MEDICINE IN NON-SMALL CELL LUNG CANCER.	Mol Med	2016
27161972	Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.	J Clin Oncol	2016
26992943	Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.	Haematologica	2016
26832770	Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.	J Natl Cancer Inst	2016
26733613	A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.	Clin Cancer Res	2016
27030594	Somatic PIK3CA mutations as a driver of sporadic venous malformations.	Sci Transl Med	2016
26901067	Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.	Nat Genet	2016
25336442	Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.	Stem Cells	2015

1 - 50 of 170

Xinmin Li

University of California los angeles

Career Start Year 2008

Number of shared co-authors 1

Ritu Roy

University of California San Francisco.

Career Start Year 2007

Number of shared co-authors 2

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 1

Joel S Parker

Lineberger Cancer Center, University of North Carolina

Career Start Year 2002

Number of shared co-authors 37

Michael Slifker

Fox Chase Cancer Center

Career Start Year 2002

Number of shared co-authors 1

Yuelin J Zhu

National Cancer Institute, National Institutes of Health

Career Start Year 2002

Number of shared co-authors 3

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 6

Jan Koster

Amsterdam University Medical Centers location AMC

Career Start Year 1999

Number of shared co-authors 10

Ru-Fang Yeh

Genentech Inc.

Career Start Year 1999

Number of shared co-authors 3

Jonathan K Killian

From Foundation Medicine

Career Start Year 1999

Number of shared co-authors 5

Paul T Spellman

Oregon Health & Science University Hospital.

Career Start Year 1998

Number of shared co-authors 27

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 2

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 10

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 12

David Cogdell

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 0

Yi-Mi Wu

University of Michigan Medical School ann arbor

Career Start Year 1995

Number of shared co-authors 22

Woong-Yang Park

Samsung Genome Institute, Samsung Medical Center

Career Start Year 1995

Number of shared co-authors 10

Anamaria A Camargo

Hospital Sirio-Libanes

Career Start Year 1994

Number of shared co-authors 1

Samuel Aparicio

University of British Columbia

Career Start Year 1993

Number of shared co-authors 18

Marco A Marra

University of British Columbia

Career Start Year 1993

Number of shared co-authors 43

Abdel G Elkahloun

National Human Genome Research Institute

Career Start Year 1990

Number of shared co-authors 3

Sean M Grimmond

The University of Melbourne

Career Start Year 1990

Number of shared co-authors 15

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 10

Mark A Watson

Washington University School of Medicine

Career Start Year 1987

Number of shared co-authors 22

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 6

Andrew D Cherniack

Dana-Farber Cancer Institute

Career Start Year 1984

Number of shared co-authors 52

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 5

David J Adams

Wellcome Sanger Institute

Career Start Year 1980

Number of shared co-authors 14

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 23

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1970

Number of shared co-authors 31

row(s) 1 - 30 of 30